publication venue for
- Treatment of High-Risk Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial. 1595-1604. 2014
- Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. 859-865. 2013
- Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. 3138-3145. 2013
- Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the programa espanol de tratamiento en hematologia pediatric-based protocol ALL-96. 1843-1849. 2008
- Pharmacokinetic (PK) guide for dose adjustments in cancer patients treated with 5-fluorouracil (5FU) infusions. Preliminary results. 624-624. 2008
- Phase III study of Capecitabine plus Oxaliplatin (XELOX) versus continuous infusion 5-fluorouracil plus Oxaliplatin (FUOX) as first-line therapy of metastatic colorectal cancer: Final report of the Spanish TTD Cooperative Group Trial. 4224-4230. 2007
- Prospective study of FGFR3 mutations as a prognostic factor in non-muscle invasive urothelial bladder carcinomas. 3664-3671. 2006
- Irinotecan in combination with fluorouracil in a 48 hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer. A Spanish Cooperative Group for the Treatment of Digestive Tumors Study. 3545-3551. 2005
- Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. 3950-3957. 2004
- Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.. 1430-1438. 2004
- An Open Phase II Study of the Efficacy and Tolerability of Two Dosing Regimen of the Farnesyl Transferase Inhibitor R115777 in Advanced Breast Cancer. 2492-2499. 2003
- Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial. 3207-3213. 2003
- Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 As Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma. 1301-1306. 2003
- Phase II Trial of Gemcitabine plus Paclitaxel in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.. 1071-1077. 2001